Company Overview
Vinehealth Digital Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Monday 12 November 2018, so this is a well established company. Vinehealth Digital Limited has been in business for 7 years and 4 months. The accounts status is micro entity and the accounts are next due on Wednesday 30 September 2026.
Registered Address

107 Station Street Burton-On-Trent, Staffordshire, DE14 1SZ
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameVINEHEALTH DIGITAL LIMITED
Company Number11672175
Registered Office Address107 Station Street Burton-On-Trent
 DE14 1SZ
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date12/11/2018
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryMICRO ENTITY
Returns Next Due Date10/12/2019
Directors & Members
Show Resigned
John Bradshaw - Director
(British, 71 years old, born December 1955)
Appointed 18 January 2024
 Active
Christian Tucat - Director
(Italian, 57 years old, born September 1969)
Appointed 19 November 2024
 Active
Secretaries
John Bradshaw - Secretary
Appointed 18 January 2024
 Active
Other Company Directorships
John Bradshaw
APPLIED DISPENSARY SERVICES LIMITED
ARGONAUT BIDCO LIMITED
ARGONAUT MIDCO LIMITED
ARGONAUT TOPCO LIMITED
DMWSL 691 LIMITED
EGX GROUP LIMITED
EGX LIMITED
HALCYON ACQUISITIONS LIMITED
HALCYON FINANCING LIMITED
HALCYON MIDCO LIMITED
HEALTHCARE AT HOME (EUROPE) LIMITED
HEALTHCARE AT HOME EUROPE B.V.
HEALTHCARE AT HOME LIMITED
HEALTHCARE AT HOME SPECIALITY PHARMACEUTICALS LIMITED
HEALTHCARE AT HOME TRUSTEES LIMITED
HOSPITAL AT HOME LIMITED
INVENTIVE SOLUTIONS LTD
J.R.BRADSHAW LIMITED
MEDICAL VISITS LIMITED
MEDICINES INTELLIGENCE LIMITED
MEDIHOME (UK) LIMITED
MEDIHOME LIMITED
MERIDIAN PHARMASERVICES LIMITED
PHARMASERVICE LIMITED
REFER2US UK LIMITED
SCIENSUS INTERNATIONAL B.V.
SCIENSUS LOGISTICS LIMITED
SCIENSUS LTD
SCIENSUS PHARMA SERVICES LIMITED
SCIENSUS2 LIMITED
TARMAC NOMINEES LIMITED
TARMAC NOMINEES TWO LIMITED
TARMAC SAFETYDECK LIMITED
TELECARE LIMITED
Christian Tucat
HALCYON ACQUISITIONS LIMITED
HALCYON FINANCING LIMITED
HALCYON MIDCO LIMITED
HALCYON TOPCO LIMITED
HEALTHCARE AT HOME (EUROPE) LIMITED
HEALTHCARE AT HOME LIMITED
MEDICINES INTELLIGENCE LIMITED
SCIENSUS INTERNATIONAL B.V.
SCIENSUS LOGISTICS LIMITED
SCIENSUS LTD
SCIENSUS PHARMA SERVICES LIMITED
SHARPVIEW OPHTHALMOLOGY LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 30-Nov-2022 30-Nov-2021
Balance Sheet
Fixed Assets 22,927 22,927 8,649
Current Assets 2,462,248 2,462,248 4,131,343
Creditors Due Within One Year 256,632 256,632 74,014
Working Cap 2,205,616 2,205,616 4,057,329
Total Assets Less Current Liabilities 2,228,543 2,228,543 4,065,978
Long-term Liabilities 0 0 0
Net Assets 2,228,543 2,228,543 4,065,978
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 2,228,543 2,228,543 4,065,978
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 30-Nov-2022 30-Nov-2021
Tangible Fixed Assets - - -
Fixed Assets 0.9% 0.9% 0.2%
Stocks Inventory - - -
Debtors 8.5% 8.5% 4.1%
Cash Bank In Hand 90.5% 90.5% 95.6%
Current Assets 99.1% 99.1% 99.8%
Creditors Due Within One Year 10.3% 10.3% 1.8%
Net Current Assets Liabilities 88.8% 88.8% 98.0%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 89.7% 89.7% 98.2%
Capital Employed - - -
Total Assets Less Current Liabilities 89.7% 89.7% 98.2%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 30-Nov-2022 30-Nov-2021
Liquidity Ratio 9.6 9.6 55.8
Solvency Ratio 9.7 9.7 55.9
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 1
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 30-Nov-2022 30-Nov-2021
Assets 2,485,175 2,485,175 4,139,992
Debt 256,632 256,632 74,014
Net Assets/Debt 2,228,543 2,228,543 4,065,978

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around DE14 1SZ
SCIENSUS2 LIMITED
Suite A 7th Floor City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
ARGONAUT BIDCO LIMITED
Suite A 7th Floor, City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
ARGONAUT MIDCO LIMITED
Suite A 7th Floor City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
EGX GROUP LIMITED
Suite A, 7th Floor, City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
ARGONAUT TOPCO LIMITED
Suite A 7th Floor City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
TELECARE LIMITED
107 Station Street, Burton-On-Trent, Staffordshire, DE14 1SZ
SCIENSUS PHARMA SERVICES LIMITED
107 STATION STREET, BURTON-ON-TRENT, STAFFORDSHIRE, DE14 1SZ
DMWSL 691 LIMITED
107 Station Street, Burton-On-Trent, Staffordshire, DE14 1SZ
107 STATION STREET LIMITED
C/O Begbies Traynor 340, Deansgate, Manchester, DE14 1SZ
HEALTHCARE AT HOME TRUSTEES LIMITED
Suite A, 7th Floor, City Gate East, Tollhouse Hill, Nottingham, DE14 1SZ
Document Filings
Registered office address changed from 107 Station Street Burton-on-Trent Staffordshire DE14 1SZ England to 20 Eastbourne Terrace London W2 6LG on 12 January 2026
Confirmation statement made on 19 November 2025 with updates
Termination of appointment of Francesca Geretto as a director on 14 November 2025
Current accounting period shortened from 31 March 2026 to 31 December 2025
Confirmation statement made on 19 November 2024 with updates
Appointment of Christian Tucat as a director on 19 November 2024
Termination of appointment of Darryn Stanley Gibson as a director on 18 November 2024
Appointment of Francesca Geretto as a director on 14 November 2024
Current accounting period extended from 30 November 2024 to 31 March 2025
Termination of appointment of John Spencer Sheridan as a director on 30 April 2024
Particulars of variation of rights attached to shares
Change of share class name or designation
Registration of charge 116721750001, created on 1 February 2024
Memorandum and Articles of Association
Resolutions
Appointment of Darryn Stanley Gibson as a director on 18 January 2024
Appointment of John Richard Bradshaw as a secretary on 18 January 2024
Appointment of Mr John Spencer Sheridan as a director on 18 January 2024
Registered office address changed from Vinehealth 124 City Road London EC1V 2NX United Kingdom to 107 Station Street Burton-on-Trent Staffordshire DE14 1SZ on 23 January 2024
Appointment of Mr John Richard Bradshaw as a director on 18 January 2024
Termination of appointment of Kirill Tasilov as a director on 18 January 2024
Termination of appointment of Christopher David George Smith as a director on 18 January 2024
Termination of appointment of Rayna Patel as a director on 18 January 2024
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free